| Net Cash Provided by (Used in) Operating Activities |
$54,821,000 |
USD |
-52% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$4,548,000 |
USD |
-24% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$25,417,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$24,856,000 |
USD |
90% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$115,752,000 |
USD |
-69% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$220,000,000 |
USD |
118% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$220,000,000 |
USD |
118% |
Q4 2024 |
FY 2024 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$380,438,000 |
USD |
-72% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$56,677,000 |
USD |
62% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
10,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Share-based Payment Arrangement, Expense |
$80,906,000 |
USD |
56% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |